堿性成纖維細胞生長因子受體1抗體,Anti-FGFR1抗體Background: Fibroblast growth factors (FGFs) produce mitogenic and angiogenic effects in target cells by signaling through the cellular surface tyrosine kinase receptors. There are four members of the FGF receptor family: FGFR-1 (flg), FGFR-2 (bek, KGFR), FGFR-3 and FGFR-4. Each receptor contains an extracellular ligand binding domain, a transmembrane region and a cytoplasmic kinase domain (1). Following ligand binding and dimerization, the receptors are phosphorylated at specific tyrosine residues (2). Seven tyrosine residues in the cytoplasmic tail of FGFR-1 can be phosphorylated: Tyr463, Tyr583, Tyr585, Tyr653, Tyr654, Tyr730 and Tyr766. Tyrosine 653 and 654 are important for catalytic activity of the activated FGFR and are essential for signaling (3). The other phosphorylated tyrosine residues may provide docking sites for downstream signaling components such as Crk and PLCgamma
堿性成纖維細胞生長因子受體1抗體,Anti-FGFR1抗體別 名 bFGF R; BFGFR; C FGR; CD 331; CD331; CD331 antigen; CEK; FGFBR; FGFR 1; FGF Receptor 1; Fibroblast growth factor receptor 1; FLG; FLG protein; FLJ14326; FLT 2; FLT2; Fms like tyrosine kinase 2; Fms related tyrosine kinase 2; Fms related tyrosine kinase 2 Pfeiffer syndrome; H2; H3; H4; H5; HBGFR; Heparin binding growth factor receptor; Hydroxyaryl protein kinase; KAL 2; KAL2; MFR; N SAM; N sam tyrosine kinase; Protein tyrosine kinase; Tyrosylprotein kinase; Basic fibroblast growth factor receptor 1
堿性成纖維細胞生長因子受體1抗體,Anti-FGFR1抗體相關產品：
Anti-P63 protein抗體說明書，P63 腫瘤抑制基因抗體
Anti-P73 protein抗體說明書，P73腫瘤抑制基因抗體
Anti-p70 S6 Kinase抗體說明書，抗核糖體S6蛋白激酶抗體
Anti-phospho-P70 S6 Kinase beta抗體說明書，磷酸化核糖體S6蛋白激酶抗體
Anti-PACAP2/VIP receptorII抗體說明書，血管活性腸肽受體-II抗體
Anti-PACAP1/VIP receptor-I抗體說明書，血管活性腸肽-I抗體
Anti-PACAP-27/38抗體說明書，腺苷酸環化酶激活肽-27/38抗體
Anti-PACAP-38抗體說明書，腺苷酸環化酶激活肽-38抗體
Anti-PADI4/PAD4抗體說明書，關節炎相關基因抗體
Anti-PAF抗體說明書，血小板活化因子抗體
Anti-PALB2抗體說明書，乳腺癌易感基因相關蛋白2
Anti-PAFAH2/Lp-PLA2/PLA2G7抗體說明書，抗脂蛋白磷脂酶A2抗體
Anti-PAFR/PTAFR抗體說明書，抗血小板活化因子受體抗體
Anti-PAI-1抗體說明書，纖溶酶原激活物抑制因子抗體
Anti-PAI-2抗體說明書，纖溶酶原激活物抑制因子2抗體
